Ransom Natural Products
Extracts for Pharmaceuticals and Food & Drink Products
Our newly-commissioned, multi-million pound, Good Manufacturing Practice (GMP) botanical extract manufacturing facility supplies botanical Active Pharmaceutical Ingredients (API's) to the pharmaceutical industry, as well as functional ingredients to the food and drink sectors.
We have for many years been producing established extracts such as Burdock, Ginseng, Echinacea, Elderflower and Guarana for traditional soft drink manufacturers. Market trends, influenced to some extent by the pioneering development activities of the Ransom formulation experts, have produced a UK adult soft drinks market today of some 500 million litres per year.
A very broad international supplier base provides Ransom with a huge range of raw materials, from our own wild-harvested English elderflower to obscure and exotic roots from the tropics. Our plant knowledge, grower relationships and buying experience ensure that this diverse range of high quality raw materials is available all year round.
The positive and beneficial effects of many of our extracts, combined with an increasing consumer awareness of the advantages of natural, botanically-derived additives gives our customers' brands a marketing edge - a unique selling point that can keep them ahead of the competition.
Our technical team is constantly working on adding functionality to many products for a wide range of multi-national food and drink companies, providing natural functional benefit in milks, ice creams, yoghurts, cereals and hot beverages, as well as in adult soft drinks.
Over half of our pharmaceutical extracts are exported and as the UK's leading supplier, we strive to develop and improve our already extensive range to keep up with new discoveries. Our customer base now extends from the smallest specialised natural supplements manufacturers to hi-tech pharmaceutical giants.
Ransom's development team is part of an EU-funded consortium researching the application of cannabis extracts to treat rheumatoid arthritis and migraine.
